Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Long-Term Investments (2018 - 2024)

Cryo Cell International (CCEL) has disclosed Long-Term Investments for 13 consecutive years, with $308000.0 as the latest value for Q1 2024.

  • On a quarterly basis, Long-Term Investments changed 0.0% to $308000.0 in Q1 2024 year-over-year; TTM through Feb 2024 was $308000.0, a 0.0% change, with the full-year FY2023 number at $308000.0, changed 0.0% from a year prior.
  • Long-Term Investments was $308000.0 for Q1 2024 at Cryo Cell International, roughly flat from $308000.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $308000.0 in Q1 2020 to a low of $308000.0 in Q1 2020.
  • A 5-year average of $308000.0 and a median of $308000.0 in 2020 define the central range for Long-Term Investments.
  • Biggest YoY gain for Long-Term Investments was 0.0% in 2020; the steepest drop was 0.0% in 2020.
  • Cryo Cell International's Long-Term Investments stood at $308000.0 in 2020, then changed by 0.0% to $308000.0 in 2021, then changed by 0.0% to $308000.0 in 2022, then changed by 0.0% to $308000.0 in 2023, then changed by 0.0% to $308000.0 in 2024.
  • Per Business Quant, the three most recent readings for CCEL's Long-Term Investments are $308000.0 (Q1 2024), $308000.0 (Q4 2023), and $308000.0 (Q3 2023).